WO2001085904A3 - Nouveau polypeptide, proteine 9 contenant un fragment de sequence particulier d'une porine, et polynucleotide codant pour ce polypeptide - Google Patents
Nouveau polypeptide, proteine 9 contenant un fragment de sequence particulier d'une porine, et polynucleotide codant pour ce polypeptide Download PDFInfo
- Publication number
- WO2001085904A3 WO2001085904A3 PCT/CN2001/000592 CN0100592W WO0185904A3 WO 2001085904 A3 WO2001085904 A3 WO 2001085904A3 CN 0100592 W CN0100592 W CN 0100592W WO 0185904 A3 WO0185904 A3 WO 0185904A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- prion
- fragment
- human protein
- characteristic sequence
- polynucleotide encoding
- Prior art date
Links
- 102000003839 Human Proteins Human genes 0.000 title abstract 3
- 108090000144 Human Proteins Proteins 0.000 title abstract 3
- 102000029797 Prion Human genes 0.000 title abstract 3
- 108091000054 Prion Proteins 0.000 title abstract 3
- 239000012634 fragment Substances 0.000 title abstract 3
- 108091033319 polynucleotide Proteins 0.000 title abstract 3
- 102000040430 polynucleotide Human genes 0.000 title abstract 3
- 239000002157 polynucleotide Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 208000012239 Developmental disease Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
L'invention concerne un nouveau polypeptide, une protéine 9 contenant un fragment de séquence particulier d'une porine, et un polynucléotide codant pour ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment des troubles hydro-électrolytiques et des troubles du développement, de toutes sortes de tumeurs, des inflammations et des maladies immunitaires. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant pour la protéine 9 contenant un fragment de séquence particulier d'une porine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU70434/01A AU7043401A (en) | 2000-04-27 | 2001-04-23 | A novel polypeptide, a human protein 9 containing a fragment of porin specific sequence and the polynucleotide encoding the polypeptide |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00115486.9A CN1320636A (zh) | 2000-04-27 | 2000-04-27 | 一种新的多肽——人含膜孔蛋白特征性序列片段的蛋白9和编码这种多肽的多核苷酸 |
| CN00115486.9 | 2000-04-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2001085904A2 WO2001085904A2 (fr) | 2001-11-15 |
| WO2001085904A3 true WO2001085904A3 (fr) | 2002-03-28 |
Family
ID=4584932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2001/000592 WO2001085904A2 (fr) | 2000-04-27 | 2001-04-23 | Nouveau polypeptide, proteine 9 contenant un fragment de sequence particulier d'une porine, et polynucleotide codant pour ce polypeptide |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1320636A (fr) |
| AU (1) | AU7043401A (fr) |
| WO (1) | WO2001085904A2 (fr) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0970219A1 (fr) * | 1997-03-25 | 2000-01-12 | Her Majesty in Right of Canada, as represented by the Minister of Health and Welfare Canada | Gene de porine extrait de campylobacter jejuni, produits apparentes et leurs utilisations |
-
2000
- 2000-04-27 CN CN00115486.9A patent/CN1320636A/zh active Pending
-
2001
- 2001-04-23 AU AU70434/01A patent/AU7043401A/en not_active Abandoned
- 2001-04-23 WO PCT/CN2001/000592 patent/WO2001085904A2/fr active Application Filing
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0970219A1 (fr) * | 1997-03-25 | 2000-01-12 | Her Majesty in Right of Canada, as represented by the Minister of Health and Welfare Canada | Gene de porine extrait de campylobacter jejuni, produits apparentes et leurs utilisations |
Also Published As
| Publication number | Publication date |
|---|---|
| AU7043401A (en) | 2001-11-20 |
| WO2001085904A2 (fr) | 2001-11-15 |
| CN1320636A (zh) | 2001-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002014368A8 (fr) | Nouvelles proteines et acides nucleiques codant pour ces proteines | |
| WO2002055705A3 (fr) | Proteines et acides nucleiques codant ces proteines | |
| WO2002057453A3 (fr) | Polypeptides et acides nucleiques codant ces derniers | |
| WO2002068649A3 (fr) | Proteines et acides nucleiques les codant | |
| WO2002057450A3 (fr) | Proteines et acides nucleiques les codant | |
| WO2001090155A3 (fr) | Nouvelles proteines et acides nucleiques codant pour ces proteines | |
| WO2002081518A3 (fr) | Proteines, polynucleotides les codant et leurs procedes d'utilisation | |
| WO2002068652A3 (fr) | Proteines et acides nucleiques codant ces proteines | |
| WO2002029058A3 (fr) | Nouvelles proteines humaines, polynucleotides codant pour ces proteines et methodes d'utilisation associees | |
| WO2001081578A3 (fr) | Nouvelles proteines et acides nucleiques codant ces dernieres | |
| WO2002081510A3 (fr) | Proteines, polynucleotides codant pour celles-ci et methodes d'utilisation | |
| WO2002016599A3 (fr) | Nouvelles proteines et acides nucleiques les codant | |
| WO2002055704A3 (fr) | Proteines, polynucleotides codant pour elles et procedes d'utilisation correspondants | |
| WO2002046229A3 (fr) | Nouvelles proteines et acides nucleiques codant celles-ci | |
| WO2002066643A3 (fr) | Proteines, polynucleotides codant pour ces proteines et procedes d'utilisation | |
| WO2002029038A3 (fr) | Nouvelles proteines, acides nucleiques codant ces derniers et anticorps diriges contre ces proteines | |
| WO2002055702A3 (fr) | Protéines humaines, polynucléotides les codant et procédés d'utilisation correspondants | |
| WO2001066747A8 (fr) | Nouvelles proteines et acides nucleiques codant lesdites proteines | |
| WO2002057452A3 (fr) | Proteines, polynucleotides codant pour elles et leurs procedes d'utilisation | |
| WO2001085904A3 (fr) | Nouveau polypeptide, proteine 9 contenant un fragment de sequence particulier d'une porine, et polynucleotide codant pour ce polypeptide | |
| WO2002068647A3 (fr) | Proteines, polynucleotides codant ces proteines et procedes d'utilisation correspondants | |
| WO2002026826A3 (fr) | Nouvelles proteines et acides nucleiques codant pour celles-ci | |
| WO2002008289A3 (fr) | Nouvelles proteines et acides nucleiques codant ces proteines | |
| WO2001094416A3 (fr) | Nouvelles proteines et acides nucleiques qui les codent | |
| WO2002030974A3 (fr) | Nouvelles proteines et acides nucleiques codant pour celles-ci |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |